Pamela Ann Connealy - 26 Nov 2024 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role: CFO & COO
Signature: /s/ Pamela Connealy
Issuer symbol: PYXS
Transactions as of: 26 Nov 2024
Transactions value $: $174,364
Form type: 4
Filing time: 27 Nov 2024, 17:09:59 UTC
Previous filing: 21 Jun 2024
Next filing: 23 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PYXS	Common Stock	Purchase	$10.9K	+5.45K	+0.49%	$2.00	1.12M	26 Nov 2024	By Trust	F1
transaction	PYXS	Common Stock	Purchase	$163K	+83.4K	+7.47%	$1.96	1.2M	26 Nov 2024	By Spouse	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held directly by the Personal Def Ben Pln Trust, a revocable trust for which the Reporting Person and their spouse are the trustees.
F2	The price reported in column 4 is a weighted-average price.These shares were purchased in multiple transactions at prices ranging from $1.93 to $1.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Content

These shares are held directly by the Personal Def Ben Pln Trust, a revocable trust for which the Reporting Person and their spouse are the trustees.

The price reported in column 4 is a weighted-average price.These shares were purchased in multiple transactions at prices ranging from $1.93 to $1.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.